On Invalid Date, Acumen Pharmaceuticals (NASDAQ: ABOS) reported Q1 2023 earnings per share (EPS) of -$0.28, up 21.74% year over year. Total Acumen Pharmaceuticals earnings for the quarter were -$11.31 million. In the same quarter last year, Acumen Pharmaceuticals's earnings per share (EPS) was -$0.23.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.